Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
批准号:
6913605
负责人:
Jeffrey T Holt
金额:
$22.96万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2007-05-31
中文摘要
BRCA2基因是一种癌症易感基因,在乳腺癌、前列腺癌、卵巢癌、食道癌和胰腺癌中成熟。作为对这些批评的回应,我们对这一提议进行了显著修改,以研究小鼠BRCA2缺陷细胞(BRCA2-)而不是人类BRCA2缺陷Vance细胞,因为小鼠细胞中的遗传缺陷更简单。我们在小鼠BRCA2细胞中的初步数据显示,在BRCA2缺陷细胞中,Rad51被caspase-3快速切割,并且BRCA2或Rad51的过表达,或caspase-3的抑制逆转放射性和DNA修复缺陷。caspase-3抗性Rad51突变体(D- A187Rad51)比野生型Rad51在更大程度上逆转了brca2中的无线电敏感性和DNA修复,当这两种蛋白在接近生理水平时表达。我们最近纯化了Rad51和caspase-3蛋白,以便进行体外机制研究。我们提出的新数据显示Rad51主要是在brca2-细胞质中,并且野生型brca2表达将Rad51重新定位到细胞核,而突变型brca2表达不影响Rad51的定位。这些资金导致以下假设:BRCA2通常在双链DNA断裂修复中起作用;2. BRCA2和Rda51在相同的生化途径中起作用,介导DNA修复;3. BRCA2通过驻留caspase-3和其他蛋白酶的降解来稳定Rad51;4. BRCA2影响Rad51的核定位。为了检验假设,我们提出了这些目标。目的1:确定介导双链断裂修复和肿瘤发生的BRCA2蛋白的功能域。目的2:了解BRCA2缺陷癌细胞中已知的额外突变是否会导致BRCA2细胞的辐射敏感性和DNA修复缺陷。目的3:通过体外实验确定BRCA2- Rad51相互作用的机制和体内意义。目的4:分析BRCA2- Rad51定位的机制。目标5:开发和使用活体成像方法实时研究Rad51在活细胞中的定位和DNA修复。
英文摘要
The BRCA2 gene is a cancer predisposition gene, which is matured in breast cancer, prostate cancer, ovarian cancer, esophageal cancer , and pancreatic cancer. In response to the critique, we have markedly modified this proposal to study mouse BRCA2 defective cells (BRCA2--) instead of human BRCA2 defective Vance cells, since the genetic defect in the mouse cells is simpler. Our preliminary data in mouse BRCA2-- cells shows that Rad51 is rapidly cleaved by caspase-3 in BRCA2 defective cells and that overexpression of BRCA2 or Rad51, or inhibition of caspase-3 reverse radioactivity and the DNA repair defect. A caspase-3 resistant Rad51 mutant (D- A187Rad51) reverses radio sensitivity and the DNA repair in brca2-- to a greater extent than wildtype Rad51 when both proteins are expressed at near physiologic levels. We have recently purified Rad51 and caspase-3 proteins to allow in vitro mechanistic studies. We present new data showing Rad51 is mostly cytoplasmic in brca2--, and that wildtype BRCA2 expression relocates Rad51 to the nucleus whereas mutant BRCA2 expression does not effect Rad51 localization. These fundings lead to the following hypotheses: 1. BRCA2 normally functions in double strand DNA break repair; 2. BRCA2 and Rda51 function in the same biochemical pathway mediating DNA repair; 3. BRCA2 stabilizes Rad51 by inhabiting degradation by caspase-3 and other proteases; 4. BRCA2 influences nuclear localization of Rad51. To test hypothesis we propose these aims. Aim 1: Determine the functional domains of BRCA2 protein which mediate double strand break repair and tumorigenesis. Aim 2: See if known additional mutations in BRCA2 defective cancer cells contribute to radiation sensitivity & DNA repair defects in brca2-- cells. Aim 3: Determine the mechanism and in vivo significance off BRCA2- Rad51 interactions by in vitro assays. Aim 4: Analyze mechanism of BRCA2- Rad51 localization. Aim 5: Develop and use in Vivo imaging methods to study Rad51 localization and DNA repair in living cells, in real time.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1667/rr1290.1
发表时间:
2010-07
期刊:
Radiation research
影响因子:
3.4
作者:
[Nelson AC, Holt JT]
通讯作者:
Holt JT
DOI:
10.1002/mc.20463
发表时间:
2009-02
期刊:
MOLECULAR CARCINOGENESIS
影响因子:
4.6
作者:
[Brown, Erika T., Holt, Jeffrey T.]
通讯作者:
Holt, Jeffrey T.
IHC Test for BRCA1 Hereditary Ovarian Cancer
-
批准号:8239640
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2010
-
负责人:Jeffrey T Holt
-
依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
-
批准号:8259213
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2010
-
负责人:Jeffrey T Holt
-
依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
-
批准号:7804771
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2010
-
负责人:Jeffrey T Holt
-
依托单位:
PARP Inhibitor Targeted Therapy for Breast Cancer
-
批准号:7481522
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2008
-
负责人:Jeffrey T Holt
-
依托单位:
Development of a BRCA Breast Cancer Diagnostic Test
-
批准号:7325640
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2007
-
负责人:Jeffrey T Holt
-
依托单位:
BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test
-
批准号:7404496
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2007
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6399060
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6559526
-
项目类别:
-
资助金额:$3.23万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6514387
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6608872
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6803434
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
CANCER GENETICS
-
批准号:6103155
-
项目类别:
-
资助金额:$7.03万
-
财政年份:1998
-
负责人:Jeffrey T Holt
-
依托单位:
CORE--VIRAL VECTOR
-
批准号:6103167
-
项目类别:
-
资助金额:$7.03万
-
财政年份:1998
-
负责人:Jeffrey T Holt
-
依托单位:
OVARIAN CANCER GENE THERAPY WITH BRCA1
-
批准号:6115614
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:Jeffrey T Holt
-
依托单位:
CANCER GENETICS
-
批准号:6237633
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
OVARIAN CANCER GENE THERAPY WITH BRCA1
-
批准号:6276848
-
项目类别:
-
资助金额:$3.29万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
TISSUE TARGETED RETROVIRAL VECTORS IN BREAST CANCER
-
批准号:6246734
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
OVARIAN CANCER GENE THERAPY WITH BRCA1
-
批准号:6246777
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
CORE--VIRAL VECTOR
-
批准号:6237645
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
AFAP-110 as a cSrc activator in breast cancer
-
批准号:8288607
-
项目类别:
-
资助金额:$22.78万
-
财政年份:1994
-
负责人:Jeffrey T Holt
-
依托单位:
海外基金